DNMT1 Protein

DNMT1 Protein

Introduction

Dnmt1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

DNA Methyltransferase 1 (DNMT1) is the primary maintenance DNA methyltransferase responsible for copying [DNA methylation](/entities/dna-methylation) patterns during DNA replication[@robertson1999]. It catalyzes the addition of methyl groups to cytosine residues in CpG dinucleotides, playing essential roles in genomic imprinting, X-chromosome inactivation, and cellular differentiation. DNMT1 dysfunction is implicated in Alzheimer's disease, Parkinson's disease, and various cancers[@esteller2002].

DNMT1 Protein

Introduction

Dnmt1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

DNA Methyltransferase 1 (DNMT1) is the primary maintenance DNA methyltransferase responsible for copying [DNA methylation](/entities/dna-methylation) patterns during DNA replication[@robertson1999]. It catalyzes the addition of methyl groups to cytosine residues in CpG dinucleotides, playing essential roles in genomic imprinting, X-chromosome inactivation, and cellular differentiation. DNMT1 dysfunction is implicated in Alzheimer's disease, Parkinson's disease, and various cancers[@esteller2002].

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">DNMT1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>DNA Methyltransferase 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[DNMT1](/genes/dnmt1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P26358](https://www.uniprot.org/uniprot/P26358)</td></tr>
<tr><td><strong>PDB ID(s)</strong></td><td>3AV0, 4WXX</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>183 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Nucleus</td></tr>
<tr><td><strong>Protein Family</strong></td><td>DNA methyltransferase family</td></tr>
<tr><td><strong>Expression</strong></td><td>Ubiquitous, high in proliferating cells</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-782e55f6" style="color:#ce93d8" title="Score: 0.35">DNMT1-Targeting Antisense Oligonucleotid...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">246 edges</a></td>
</tr>
</table>
</div>

Structure

Domain Architecture

DNMT1 contains multiple functional domains[@syeda2011]:

• RFTS domain (1-289): Targets DNMT1 to replication foci
• Zn-binding domain (290-367): CXXC motif for CpG island recognition
• BAH domain (375-500): Bromo-adjacent homology, protein interactions

• S-adenosylmethionine (SAM) binding site: Methyl donor
• Catalytic loop: Contains conserved motifs for methyl transfer

Mechanism

• Maintenance methylation: Recognizes hemimethylated CpG sites
• Replication foci targeting: Binds PCNA at replication forks
• Allosteric activation: Binding to unmethylated DNA stimulates activity

Function

DNA Methylation

• CpG methylation: 5-methylcytosine formation
• Epigenetic inheritance: Maintains methylation patterns through cell division
• Hemimethylated substrate recognition: Preferred substrate

Transcriptional Regulation

• Gene silencing: Methylation of promoter CpG islands represses transcription
• Genomic imprinting: Parent-of-origin-specific methylation
• X-chromosome inactivation: Random silencing in females

Cellular Processes

• Cell differentiation: Lineage-specific methylation patterns
• DNA repair: Methylation guides repair machinery
• Chromatin structure: [Histone modifications](/entities/histone-modifications) work with DNA methylation

Role in Disease

Alzheimer's Disease

DNMT1 alterations in AD include[@chouliaras2013]:

• Global hypomethylation: Reduced DNA methylation in AD brain
• Specific gene changes: [APP](/entities/app-protein), [BACE1](/entities/bace1) promoter methylation altered
• Age-related changes: DNMT1 activity declines with age
• Therapeutic potential: DNMT modulators being explored

Parkinson's Disease

• [α-Synuclein](/proteins/alpha-synuclein) methylation: DNMT1 affects SNCA methylation
• Global changes: Altered methylation patterns in PD brain
• Environmental factors: Pesticide exposure affects DNMT1

Cancer

• Hyperactivity: DNMT1 overactive in many cancers
• Tumor suppressor silencing: Methylation of growth regulatory genes
• Therapeutic target: DNMT inhibitors used in cancer therapy

ICF Syndrome

• Immunodeficiency: Caused by DNMT1 mutations
• Centromeric instability: Chromosome abnormalities
• Facial dysmorphism: Characteristic features

Therapeutic Approaches

DNMT Inhibitors

| Drug | Type | Approval | Indication |
|------|------|----------|------------|
| Azacitidine | Nucleoside analog | 2004 | MDS, AML |
| Decitabine | Nucleoside analog | 2006 | MDS, AML |
| Guadecitabine | Second-generation | Clinical trials | Various |

Challenges

• Global effects: Non-selective demethylation
• Toxicity: Cytopenia, gastrointestinal effects
• [Blood-brain barrier](/entities/blood-brain-barrier): Limited penetration

See Also

• [DNMT1 Gene](/proteins/dnmt1-protein)
• [DNA Methylation](/mechanisms/dna-methylation-neurodegeneration)
• [Epigenetics in Neurodegeneration](/mechanisms/epigenetics-ad)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [UniProt P26358](https://www.uniprot.org/uniprot/P26358)
• [PDB: DNMT1 Structure](https://www.rcsb.org/structure/3AV0)
• [DNMT1 in neurodegeneration - Nature Reviews](https://pubmed.ncbi.nlm.nih.gov/22545048/)

Background

The study of Dnmt1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Microbial Metabolite-Mediated α-Synuclein Disaggregation](/hypothesis/h-74777459) — <span style="color:#ffd54f;font-weight:600">0.43</span> · Target: SNCA, HSPA1A, DNMT1
• [DNMT1-Targeting Antisense Oligonucleotide Reset](/hypothesis/h-782e55f6) — <span style="color:#ff8a65;font-weight:600">0.35</span> · Target: DNMT1